Skip to main content
Loading market data...
ETF NYSE Arca USD

ProShares Ultra Health Care RXL

Issuer: ProShares SEC registrant: ProShares Trust Derivatives-based
Last price 66.31 USD Change: Up +2.80 Percent change: Up +4.41%

Source: Yahoo Finance (opens in a new tab) Observed · 1 day ago Quotes may be delayed

Net expense ratio
0.95%
Prospectus 7 Apr 2025
Net assets
$72.1M
As of 31 May 2026
Holdings
70
As of 31 May 2026
12-month distribution yield
0.95%
Quarterly
Asset class
Derivatives-based
From holdings

ProShares Ultra Health Care (RXL) is an exchange-traded fund listed on NYSE Arca in the United States, issued by ProShares. Its category is Derivatives-based. Its last price was US$66.31 on 20 Oct 2026. Its net expense ratio is 0.95% a year, from its prospectus dated 7 Apr 2025. It reported net assets of US$72.08 million as of 31 May 2026. Its latest holdings report lists 70 holdings as of 31 May 2026. Over the last 12 months it paid distributions of US$0.63 a unit, a 12-month distribution yield of 0.95%, paid quarterly.

General information only: nothing on TakeProfits takes into account your objectives, financial situation or needs, and it isn't personal financial advice or a recommendation to buy or sell anything. Consider whether it suits you and get advice from a licensed adviser before acting. Market data may be delayed and comes from third-party sources.

Fees

Total annual operating expenses (gross)
1.05%
Net, after fee waivers or reimbursements
0.95%
Management fee
0.75%
Prospectus date
7 Apr 2025
Filed with the SEC
7 Apr 2025

Size and reporting

Net assets
$72,080,935
Total assets
$79,486,672
Holdings as of
31 May 2026
Report made public
28 Jul 2026 (58 days after the month end)

Net assets are for the whole fund series, which for some funds (Vanguard's, for example) also includes mutual fund share classes.

Top holdings

Largest 25 of 70 positions, as of 31 May 2026. Weight is the percent of net assets the fund reported.

RXL top holdings as of 31 May 2026
# Holding Identifier Weight Value (USD) Type Country Currency
1 Eli Lilly & Co. US5324571083 12.67% $9.1M Equity (common) United States USD
2 ProShares GENIUS Money Market ETF US74350P6916 11.81% $8.5M Other United States USD
3 Johnson & Johnson US4781601046 7.86% $5.7M Equity (common) United States USD
4 AbbVie, Inc. US00287Y1091 5.57% $4.0M Equity (common) United States USD
5 UnitedHealth Group, Inc. US91324P1021 4.98% $3.6M Equity (common) United States USD
6 Merck & Co., Inc. US58933Y1055 4.26% $3.1M Equity (common) United States USD
7 Total Return Swap No identifier reported -4.13% -$3.0M Equity derivatives United States USD
8 Total Return Swap No identifier reported -3.97% -$2.9M Equity derivatives United States USD
9 Repurchase Agreement No identifier reported 2.91% $2.1M Repurchase agreements United States USD
10 Thermo Fisher Scientific, Inc. US8835561023 2.68% $1.9M Equity (common) United States USD
11 Amgen, Inc. US0311621009 2.62% $1.9M Equity (common) United States USD
12 Gilead Sciences, Inc. US3755581036 2.41% $1.7M Equity (common) United States USD
13 Intuitive Surgical, Inc. US46120E6023 2.18% $1.6M Equity (common) United States USD
14 Pfizer, Inc. US7170811035 2.15% $1.6M Equity (common) United States USD
15 Abbott Laboratories US0028241000 2.15% $1.6M Equity (common) United States USD
16 Repurchase Agreement No identifier reported 1.83% $1.3M Repurchase agreements United States USD
17 Bristol-Myers Squibb Co. US1101221083 1.68% $1.2M Equity (common) United States USD
18 CVS Health Corp. US1266501006 1.67% $1.2M Equity (common) United States USD
19 Danaher Corp. US2358511028 1.66% $1.2M Equity (common) United States USD
20 Vertex Pharmaceuticals, Inc. US92532F1003 1.64% $1.2M Equity (common) United States USD
21 Stryker Corp. US8636671013 1.52% $1.1M Equity (common) United States USD
22 Repurchase Agreement No identifier reported 1.37% $990K Repurchase agreements United States USD
23 Medtronic plc IE00BTN1Y115 1.37% $987K Equity (common) Ireland USD
24 McKesson Corp. US58155Q1031 1.32% $948K Equity (common) United States USD
25 Elevance Health, Inc. US0367521038 1.26% $905K Equity (common) United States USD

Breakdowns

Sums of reported weights over every position in the report. Totals can differ from 100% because of derivatives, borrowing and cash.

Warning: Uses derivatives

Derivative contracts in this report have a combined notional amount of 122% of net assets. The weights here show each contract's reported value, not the exposure it creates.

Asset type

Asset type by weight
TypeWeightBar
Equity (common) 78.01%
Other 11.81%
Equity derivatives -9.72%
Repurchase agreements 7.12%

Country

Country by weight
CountryWeightBar
United States 85.55%
Ireland 1.67%

Currency exposure

Currency exposure by weight
CurrencyWeightBar
US dollar (USD) 87.22%

Sector

Sector weights for holdings matched to listed stocks
SectorWeightBar
Health Care 68.33%
Industrials 5.96%
Consumer Staples 1.67%
Technology 0.38%

Source: SEC Form N-PORT (opens in a new tab) Holdings as of

Distributions

Paid in the last 12 months
$0.6310
4 payments per unit
12-month yield
0.95%
Distributions only, not total return
Frequency
Quarterly
From the gaps between ex-dates
Latest ex-date
23 Sep 2026

12-month yield = distributions per unit with an ex-date in the last 12 months ($0.6310) ÷ latest price ($66.31) × 100 = 0.95%. It looks back, so it is not a forecast; special distributions in the window are included.

Why a distribution yield is not the fund's return: yield vs total return

Distribution history table (16 payments)
RXL distributions per unit by ex-date
Ex-dateAmount per unit
23 Sep 2026$0.1260
24 Jun 2026$0.1770
25 Mar 2026$0.1440
24 Dec 2025$0.1840
24 Sep 2025$0.2030
25 Jun 2025$0.2190
26 Mar 2025$0.1340
23 Dec 2024$0.1470
25 Sep 2024$0.1285
26 Jun 2024$0.1725
20 Mar 2024$0.0860
20 Dec 2023$0.0840
22 Dec 2022$0.1065
22 Jun 2022$0.0015
23 Mar 2022$0.0455
23 Dec 2021$0.0225

Filings and sources

Compare with

Largest funds in the same category:

Up to four symbols separated by commas. ASX funds end in .AX, for example IVV.AX.

How ETF overlap is measured, with a worked example

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.

Catalyst evidence

Loading…

Loading evidence…

Supporting sources

    Skip to main content

    All resources and tools

    Market ticker

    Markets

    Research

    Tools

    My investments

    Account

    Region and currency

    Colour theme